4.6 Article

Blockchain-Based Supply Chain Systems, Interoperability Model in a Pharmaceutical Case Study

Journal

SENSORS
Volume 23, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/s23041962

Keywords

blockchain; verifiable credentials; supply chain; traceability; interoperability

Ask authors/readers for more resources

The main purpose of supply chain systems based on blockchain technology is to ensure the traceability and immutability of assets. This paper proposes a model that overcomes the challenge of tracking assets among different blockchain-based supply chain systems. The model enables asset tracking, cryptographic verification of the supply chain, standardization of asset definition, and description in multiple formats. It provides interoperability advantages over other models and has operational applications in the pharmaceutical sector.
The main purpose of supply chain systems based on blockchain technology is to take advantage of technology innovations to ensure that a tracked asset's audit trail is immutable. However, the challenge lies in tracking the asset among different blockchain-based supply chain systems. The model proposed in this paper has been designed to overcome the identified challenges. Specifically, the proposed model enables: (1) the asset to be tracked among different blockchain-based supply-chain systems; (2) the tracked asset's supply chain to be cryptographically verified; (3) a tracked asset to be defined in a standardized format; and (4) a tracked asset to be described with several different standardized formats. Thus, the model provides a great advantage in terms of interoperability between different blockchain-driven supply chains over other models in the literature, which will need to replicate the information in each blockchain platform they operate with, while giving flexibility to the platforms that make use of it and maintain the scalability of those logistic platforms. This work aims to examine the application of the proposed model from an operational point of view, in a scenario within the pharmaceutical sector.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available